Genzyme inflated its share price by concealing its problems meeting FDA standards, shareholders claim in Boston Federal Court.
Allied Capital Corp. is selling itself too cheaply to Ares Capital, in an all-stock deal valued at $648 million or $3.47 a share, shareholders claim in Montgomery County Court, Md.
Zilog is selling itself too cheaply to Ixys, shareholders say in Santa Clara County Court, Calif.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.